• clinical
  • The objective of this systematic review was to determine the benefits and harms of early (at the time of local therapy) versus deferred (at the time of clinical disease progression) androgen suppression therapy for patients with node-positive prostate cancer after local therapy. (biomedcentral.com)
  • versus
  • The data available suggest an improvement in survival and delayed disease progression but increased adverse events for patients with node-positive prostate cancer after local therapy treated with early androgen suppression therapy versus deferred androgen suppression therapy. (biomedcentral.com)
  • findings
  • Randomized controlled trials with blinding of outcome assessment, planned to determine the timing of androgen suppression therapy in node-positive prostate cancer using modern diagnostic imaging modalities, biochemical testing, and standardized follow-up schedules should be conducted to confirm these findings. (biomedcentral.com)
  • several
  • Recently, several cases of histiocytoma were observed in which histiocytes had migrated to draining lymph nodes and completely obliterated them. (wikipedia.org)